Dissociation between insulin sensitivity of glucose uptake and endothelial function in normal subjects

Diabetologia

Volumn 39, Issue 12, 1996, Pages 1477-1482

  Utriainen, T ^a   Makimattila S ^a   Virkamaki A ^a   Bergholm, R ^a   Yki Jarvinen H ^a,b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

blood flow; endothelium; nitric oxide; vasodilatation

Indexed keywords

ACETYLCHOLINE; GLUCOSE; HUMAN INSULIN; INSULIN; MONOCOMPONENT INSULIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITROPRUSSIDE SODIUM; VASOACTIVE AGENT;

ADULT; ARTICLE; BLOOD FLOW; CONTROLLED STUDY; GLUCOSE TRANSPORT; HUMAN; HUMAN EXPERIMENT; INSULIN SENSITIVITY; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM; VASODILATATION;

ACETYLCHOLINE; ADULT; COHORT STUDIES; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; FOREARM; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; HUMANS; INFUSIONS, INTRAVENOUS; INSULIN; INSULIN RESISTANCE; MALE; NITROPRUSSIDE; OMEGA-N-METHYLARGININE; REGIONAL BLOOD FLOW; VASCULAR RESISTANCE; VASODILATOR AGENTS;

EID: 0029857841     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250050601     Document Type: Article

References (56)

1. Laakso M, Edelman SV, Brechtel G, Baron AD (1990) Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance. J Clin Invest 85: 1844-1852
2. Utriainen T, Malmström R, Mäkimattila S, Yki-Järvinen H (1995) Methodological aspects, dose-response characteristics and causes of interindividual variation in insulin stimulation of limb blood flow in normal subjects. Diabetologia 38: 555-564
3. Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron AD (1994) Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J Clin Invest 94: 1172-1179
4. Scherrer U, Randin D, Vollenweider P, Vollenweider L, Nicod P (1994) Nitric oxide release accounts for insulin's vascular effects in humans. J Clin Invest 94: 2511-2515
5. Pyörälä K (1979) Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care 2: 131-141
6. Fontbonne A, Charles MA, Thibult N, et al. (1991) Hyperinsulinemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study. 15-year follow-up. Diabetologia 34: 356-361
7. Rönnemaa T, Laakso M, Pyörälä K, Kallio V, Puukka P (1991) High fasting plasma insulin is an indicator of coronary heart disease in non-insulin-dependent diabetic patients and non-diabetic subjects. Arterioscler Thromb 11: 80-90
8. Chester AH, O'Neil GS, Moncada S, Tadjkarimi S, Yacoub MH (1990) Low basal and stimulated release of nitric oxide in atherosclerotic epicardial coronary arteries. Lancet 336: 897-900
9. Egashira K, Inou T, Hirooka Y, et al. (1993) Impaired coronary blood flow response to acetylcholine in patients with coronary risk factors and proximal atherosclerotic lesions. J Clin Invest 91: 29-37
10. Vita JA, Treasure CB, Nabel EG, et al. (1990) Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation 81: 491-497
11. Quyyumi AA, Dakak N, Andrews NP, et al. (1995) Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis. J Clin Invest 95: 1747-1755
12. Karhapää P, Voutilainen E, Kovanen PT, Laakso M (1993) Insulin resistance in familial and nonfamilial hypercholesterolemia. Arterioscler Thromb 13: 41-47
13. Sheu WH-H, Shieh S-M, Fuh MM-T, et al. (1993) Insulin resistance, glucose intolerance, and hyperinsulinemia. Hypertriglyceridemia versus hypercholesterolemia. Arterioscler Thromb 13: 367-370
14. Chowienczyk PJ, Watts GF, Cockcroft J, Ritter JM (1992) Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolaemia. Lancet 340: 1430-1432
15. Craeger MA, Cooke JP, Mendelsohn ME, et al. (1990) Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest 86: 228-234
16. Leung W-H, Lau C-P, Wong C-K (1993) Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients. Lancet 341: 1496-1500
17. Panza JA, Quyyumi AA, Brush JE, Epstein SE (1990) Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 323: 22-27
18. Egashira K, Suzuki S, Hirooka Y, et al. (1995) Impaired endothelium-dependent vasodilation of large arteries and resistance coronary arteries in patients with essential hypertension. Different responses to acetylcholine and substance P. Hypertension 25: 201-206
19. Cockcroft JR, Chowienczyk PJ, Benjamin N, Ritter JM (1994) Preserved endothelium-dependent vasodilation in patients with essential hypertension. N Engl J Med 330: 1036-1040
20. McVeigh GE, Brennan GM, Johnston GD, et al. (1992) Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 35: 771-776
21. Ting HH, Timimi FK, Boles KS, Craeger SJ, Ganz P, Craeger MA (1996) Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J Clin Invest 97: 22-28
22. Ferrannini E, Buzzigoli G, Bonadonna R, et al. (1987) Insulin resistance in essential hypertension. N Engl J Med 317: 350-357
23. Pollare T, Lithell H, Berne C (1990) Insulin resistance is a characteristic feature of primary hypertension independent of obesity. Metabolism 39: 167-174
24. DeFronzo RA, Gunnarsson R, Björkman O, Olsson M, Wahren J (1985) Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus. J Clin Invest 76: 149-155
25. DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223
26. 3H]-glucose infusion and labelled or unlabelled glucose infusates. Diabet Med 9: 840-849
27. Yki-Järvinen H (1984) Insulin sensitivity during the menstrual cycle. J Clin Endocrinol Metab 59: 350-353
28. Zierler KL (1961) Theory of the use of arteriovenous concentration differences for measuring metabolism in steady state and non-steady states. J Clin Invest 40: 2111-2125
29. Clarke RSJ, Hellon RF (1957) Venous collection in forearm and hand measured by the strain-gauge and volume plethysmograph. Clin Sci 16: 103-117
30. Lukaski HC, Johnson PE, Bolonchuk WW, Lykken GI (1985) Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr 41: 810-817
31. Kadish AH, Little RL, Sternberg JC (1968) A new and rapid method for the determination of glucose by measurement of rate of oxygen consumption. Clin Chem 14: 116-131
32. Desbuquois B, Aurbach GD (1971) Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays. J Clin Endocrinol 33: 732-738
33. Syvänne M, Vuorinen-Markkola H, Hilden H, Taskinen M-R (1993) Gemfibrozil reduces postprandial lipemia in non-insulin-dependent diabetes mellitus. Arterioscler Thromb 13: 286-295
34. Chowienczyk PJ, Cockcroft JR, Ritter JM (1994) Blood flow responses to intra-arterial acetylcholine in man: effects of basal flow and conduit vessel length. Clin Sci 87: 45-51
35. Yki-Järvinen H (1995) Role of insulin resistance in the pathogenesis of NIDDM. Diabetologia 38: 1378-1388
36. Bonadonna RC, Saccomani MP, Seely L, et al. (1993) Glucose transport in human skeletal muscle. The in vivo response to insulin. Diabetes 42: 191-198
37. Lundgren F, Edén E, Arfvidsson B, Lundholm K (1991) Insulin time-dependent effects on the leg exchange of glucose and amino acids in man. Eur J Clin Invest 21: 421-429
38. Yki-Järvinen H, Young AA, Lamkin C, Foley JE (1987) Kinetics of glucose disposal in whole body and across the forearm in man. J Clin Invest 79: 1713-1719
39. Lembo G, Napoli R, Capaldo B, et al. (1992) Abnormal sympathetic overactivity evoked by insulin in the skeletal muscle of patients with essential hypertension. J Clin Invest 90: 24-29
40. 18F]fluorodeoxy-glucose and positron emission tomography. J Clin Invest 97: 1741-1747
41. Anderson EA, Hoffman RP, Balon TW, Sinkey CA, Mark AL (1991) Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest 87: 2246-2252
42. Vollenweider P, Tappy L, Randin D, et al. (1993) Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans. J Clin Invest 92: 147-154
43. Baron AD, Brechtel-Hook G, Johnson A, Hardin D (1993) Skeletal muscle blood flow. A possible link between insulin resistance and blood pressure. Hypertension 21: 129-135
44. Natali A, Santoro D, Palombo C, Cerri M, Ghione S, Ferrannini E (1991) Impaired insulin action on skeletal muscle metabolism in essential hypertension. Hypertension 17: 170-178
45. Yki-Järvinen H, Sahlin K, Ren JM, Koivisto VA (1990) Localization of rate-limiting defect for glucose disposal in skeletal muscle of insulin-resistant type 1 diabetic patients. Diabetes 39: 157-167
46. Bonadonna RC, Del Prato S, Saccomani MP, et al. (1993) Transmembrane glucose transport in skeletal muscle of patients with non-insulin-dependent diabetes. J Clin Invest 92: 486-494
47. Baron AD, Laakso M, Brechtel G, Edelman SV (1991) Mechanism of insulin resistance in insulin-dependent diabetes mellitus: a major role for reduced skeletal muscle blood flow. J Clin Endocrinol Metab 73: 637-643
48. Laakso M, Edelman SV, Brechtel G, Baron AD (1992) Impaired insulin-mediated skeletal muscle blood flow in patients with NIDDM. Diabetes 41: 1076-1083
49. Hulthén UL, Endre T, Mattiasson I, Berglund G (1995) Insulin and forearm vasodilation in hypertension-prone men. Hypertension 25: 214-218
50. O'Shaughnessy IM, Myers TJ, Stepniakowski K, et al. (1995) Glucose metabolism in abdominally obese hypertensive and normotensive subjects. Hypertension 26: 186-192
51. Dela F, Larsen JJ, Mikines KJ, Galbo H (1995) Normal effect of insulin to stimulate leg blood flow in NIDDM. Diabetes 44: 221-226
52. Tack CJJ, Smits P, Willemsen JJ, Lenders JWM, Thien T, Lutterman JA (1996) Effects of insulin on vascular tone and sympathetic nervous system in NIDDM. Diabetes 45: 15-22
53. Scherrer U, Vollenweider P, Randin D, Jéquier E, Nicod P, Tappy L (1993) Suppression of insulin-induced sympathetic activation and vasodilation by dexamethasone in humans. Circulation 88: 388-394
54. G-monomethyl-L-arginine-resistant actions of acetylcholine in human forearm vasculature. Clin Sci 88: 111-117
55. Taddei S, Virdis A, Mattei P, Natali A, Ferrannini E, Salvetti A (1995) Effect of insulin on acetylcholine-induced vasodilation in normotensive subjects and patients with essential hypertension. Circulation 92: 2911-2918
56. Petrie JR, Ueda S, Webb DJ, Elliott HL, Connell JMC (1996) Endothelial nitric oxide production and insulin sensitivity. A physiological link with implications for pathogenesis of cardiovascular disease. Circulation 93: 1331-1333